Research location

Paris

Paris, France

Published trials86

Site observations94

Linked trials published85

Page2 / 2

Research activity in Paris

Paris, France

CureCurrent currently publishes aggregate city-level research activity for this location: 86 trials and 94 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Paris

85 linked trials · page 2 of 2

Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)NCT03071692 · 2017-03-23 · 1 site observation

Music Listening for Cataract SurgeryNCT02892825 · 2017-02-02 · 1 site observation

Mobile Health InterventionNCT02955017 · 2016-11-16 · 1 site observation

Truthful Information on Chemotherapy and Its Impact on Chemotherapy at the End of LifeNCT02606149 · 2016-07-15 · 1 site observation

Impact of Rheumatoid Arthritis on the Course of Type 2 Diabetes During a Longitudinal Follow-up of 5 YearsNCT02639988 · 2016-04-13 · 1 site observation

Prospective Study of Patients With Rheumatoid Arthritis After the Age of 65NCT02686320 · 2016-03-29 · 1 site observation

Avelumab in First-line NSCLC (JAVELIN Lung 100)NCT02576574 · 2015-10-29 · 1 site observation

Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin HospitalNCT02998398 · 2015-10-01 · 1 site observation

Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate CancerNCT02003924 · 2013-10-31 · 1 site observation

Assessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular MarkersNCT02600442 · 2013-07-01 · 1 site observation

Prognosis Value of Pro-adrenomedullin in Acute Exacerbations of COPD in ERNCT01857947 · 2013-03-01 · 2 site observations

Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic RetinopathyNCT01726075 · 2013-02-01 · 1 site observation

A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's DiseaseNCT01767311 · 2012-12-20 · 1 site observation

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001NCT01760005 · 2012-12-01 · 1 site observation

ACTIVE_NOT_RECRUITING

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.NCT04623242 · 2012-12-01 · 1 site observation

Role of Endoplasmic Reticulum Stress in the Pathophysiology of Type 2 DiabetesNCT02368704 · 2012-11-01 · 1 site observation

Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart FailureNCT01661634 · 2012-07-01 · 1 site observation

Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular DiseaseNCT01609582 · 2012-06-01 · 1 site observation

Renal Denervation in Diabetic NephropathyNCT01588795 · 2012-04-01 · 1 site observation

A Study to Validate Questionnaires FLARE and OM-RA-FLARE Measuring Disease Flares in Patients With Rheumatoid Arthritis.NCT01722617 · 2012-03-01 · 2 site observations

A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects With Advanced Non-Small Cell Lung CancerNCT01454934 · 2011-12-09 · 1 site observation

Medico-economic Evaluation of IMRT by Hi Art, RapidArc, VMAT Therapy in Prostate, Cervix and Anal Canal CancersNCT01325961 · 2011-03-01 · 1 site observation

BIOmarkers of Dyspnea IN Emergency RoomNCT01227317 · 2010-04-01 · 1 site observation

Medical and Economical Impact of IGRAs Diagnosis of Latent Tuberculosis in HIV-infected PatientsNCT00805272 · 2009-02-01 · 1 site observation

Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung CancerNCT00707304 · 2008-11-01 · 1 site observation

Noninvasive Ventilatory Support After Lung Surgery in COPD PatientsNCT00428857 · 2008-06-01 · 1 site observation

Are the Continuous Glucose Monitoring Systems Able to Improve Long Term Glycaemic Control in Type 1 Diabetic Patients?NCT00726440 · 2008-02-01 · 1 site observation

Psychoeducational Programme for PD Patients With STN-DBSNCT02554370 · 2008-02-01 · 1 site observation

A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate CancerNCT00617669 · 2008-01-01 · 1 site observation

A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone MetastasesNCT00554229 · 2007-11-01 · 1 site observation

System-IGF-1 Pathway and Alzheimer's DiseaseNCT00647478 · 2007-10-01 · 1 site observation

Multicenter Assessment of the PDA-FIT System in Type 1 Diabetic PatientsNCT00629304 · 2007-09-01 · 3 site observations

Evaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid LeukemiaNCT00478985 · 2007-06-01 · 1 site observation

Study Evaluating Safety, Tolerability, And Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's DiseaseNCT00479557 · 2007-05-01 · 1 site observation

PET-CT in the Initial Staging of Breast Cancer and in the Early Assessment of Response to Neoadjuvant ChemotherapyNCT02599974 · 2006-01-01 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.